» Articles » PMID: 27789766

Obesity, Type 2 Diabetes, and Impaired Insulin-stimulated Blood Flow: Role of Skeletal Muscle NO Synthase and Endothelin-1

Overview
Date 2016 Nov 1
PMID 27789766
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

New & Noteworthy: Although impairments in endothelial signaling are hypothesized to reduce insulin-stimulated blood flow in type 2 diabetes (T2D), human studies examining these links are limited. We provide the first measures of nitric oxide synthase and endothelin-1 expression from skeletal muscle tissue containing native microvessels in individuals with and without T2D before and during insulin stimulation. Higher basal skeletal muscle expression of endothelin-1 and reduced endothelial nitric oxide phosphorylation (peNOS)/eNOS may contribute to reduced insulin-stimulated blood flow in obese T2D patients.

Citing Articles

Enhanced ECCD36 signaling promotes skeletal muscle insulin resistance in female mice.

Dada A, Habibi J, Naz H, Chen D, Lastra G, Bostick B Am J Physiol Endocrinol Metab. 2024; 327(4):E533-E543.

PMID: 39196801 PMC: 11482271. DOI: 10.1152/ajpendo.00246.2024.


Extracellular Vesicles in Metabolic and Vascular Insulin Resistance.

Malin S, Erdbrugger U J Vasc Res. 2024; 61(3):129-141.

PMID: 38615667 PMC: 11149383. DOI: 10.1159/000538197.


Plasmacytoid dendritic cells contribute to vascular endothelial dysfunction in type 2 diabetes.

Alluri K, Srinivas B, Belmadani S, Matrougui K Front Cardiovasc Med. 2023; 10:1222243.

PMID: 38094119 PMC: 10716216. DOI: 10.3389/fcvm.2023.1222243.


Neuraminidase inhibition improves endothelial function in diabetic mice.

Foote C, Ramirez-Perez F, Smith J, Ghiarone T, Morales-Quinones M, McMillan N Am J Physiol Heart Circ Physiol. 2023; 325(6):H1337-H1353.

PMID: 37801046 PMC: 10908409. DOI: 10.1152/ajpheart.00337.2023.


Skipping breakfast does not accelerate the hyperglycemia-induced endothelial dysfunction but reduces blood flow of the brachial artery in young men.

Kamoda T, Sakamoto R, Katayose M, Yamamoto S, Neki T, Sato K Eur J Appl Physiol. 2023; 124(1):295-308.

PMID: 37466651 DOI: 10.1007/s00421-023-05273-6.


References
1.
Dudzinski D, Michel T . Life history of eNOS: partners and pathways. Cardiovasc Res. 2007; 75(2):247-60. PMC: 2682334. DOI: 10.1016/j.cardiores.2007.03.023. View

2.
Padilla J, Jenkins N, Thorne P, Lansford K, Fleming N, Bayless D . Differential regulation of adipose tissue and vascular inflammatory gene expression by chronic systemic inhibition of NOS in lean and obese rats. Physiol Rep. 2014; 2(2):e00225. PMC: 3966247. DOI: 10.1002/phy2.225. View

3.
Cardillo C, Campia U, Iantorno M, Panza J . Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Hypertension. 2003; 43(1):36-40. DOI: 10.1161/01.HYP.0000103868.45064.81. View

4.
Boyle J, Thompson T, Gregg E, Barker L, Williamson D . Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010; 8:29. PMC: 2984379. DOI: 10.1186/1478-7954-8-29. View

5.
Solomon T, Haus J, Li Y, Kirwan J . Progressive hyperglycemia across the glucose tolerance continuum in older obese adults is related to skeletal muscle capillarization and nitric oxide bioavailability. J Clin Endocrinol Metab. 2011; 96(5):1377-84. PMC: 3085198. DOI: 10.1210/jc.2010-2069. View